Skip to main content

Supported by an educational grant from Axsome Therapeutics, Inc.

From a genetic perspective, delusional disorder (DD), acute psychoses (AP), psychosis otherwise not specified (PNOS), and schizoaffective disorder (SAD) do not appear to be subtypes of

While intensive treatments with psilocybin and the serotonin reuptake inhibitor (SSRI) escitalopram were associated with long-term improvements in

A systematic review published in BMJ Mental Health found weak quality evidence to support the effectiveness of several commonly prescribed pharmacological and non-pharmacological intervent

The initiation of hormonal contraception post partum was associated with an immediate increase in

Quetiapine may be more clinically effective than lithium as an augmentation option for reducing symptoms of treatment-resistant depression (TRD), a type of

Adhering to specific dietary patterns, including the Mediterranean diet, may reduce symptoms of

A novel 78-minute accelerated theta-burst stimulation (aTBS) protocol reduced depression severity in patients with treatment-resistant depression (TRD), according to resu

A genetic predisposition to traits related to neuroticism, cognitive function, and sleep patterns were significantly associated with the development of treatment-resistan

An ongoing phase 2b trial investigating adjunctive ALTO-300 in patients with major depress